Bonti's Acquisition

Bonti was acquired by Allergan on September 14, 2018.

Bonti, formerly Endurance Biotech, is focused on developing next generation neurotoxins through its proprietary platform for treating indications with strong unmet needs.…

Articles about Bonti's Acquisition: